In fact, in our cohort the rs58542926 T allele (MAF ~ 7%) displayed a 2.5-fold risk of hepatic steatosis higher than the 1.9 fold risk associated to GCKR T allele (MAF ~ 42%). This evidence concerns the gene GCKR and Hepatic steatosis.